Compounding Priorities

NASEM’s cBHT Recommendations

Why we need to use the evidence

Animal Compounding

Working for more reasonable FDA guidance

The FDA’s MOU

Bad for states, bad for compounders, bad for patients

Tricare Clawbacks

Fighting the Tricare/ESI Recoupment